Posts Tagged: healthcare

Important paper on Type 1 Diabetes and Exercise

New paper published in The Lancet Diabetes & Endocrinology recommends exercise guidelines for type 1 diabetes patients and healthcare providers. Experts from JDRF, the leading global organization focused on type 1 diabetes (T1D) research, as part of an international team of 21 researchers and clinicians led by York UniversityProfessor Michael Riddell, published first-of-its-kind guidelines to help people with type 1 diabetes exercise safely. The report, “Exercise management in type 1 diabetes: a consensus statement,” published this week in The Lancet Diabetes & Endocrinology, offers guidelines on ... Read more

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics

Toronto, Canada and Hamburg, Germany, 17 January 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP (“Fibrocor”), a Toronto-based company focused on developing first-in-class therapeutics targeting fibrotic diseases. The company was launched with CDN $ 2.8 m (approx. $ 2.1 m) financing, which includes cash from MaRS Innovation. Evotec will provide all drug discovery activities and will also receive an equity stake. Fibrocor takes a new approach to understanding and ... Read more

Acquisition of First Compound from Triphase by Celgene

Toronto-based MaRS Innovation announced today that one of its leading portfolio companies, Triphase Accelerator Corporation (Triphase), has agreed to sell assets relating to its first investigational compound, marizomib (MRZ) to U.S.-based Celgene Corporation, through an affiliate, for an undisclosed amount. Marizomib is the first major divestiture of a compound developed inside a MaRS Innovation portfolio company. Triphase was established by MaRS Innovation in partnership with the Ontario Institute for Cancer Research (OICR) and MaRS Discovery District, with a single powerful mandate of ... Read more

XOR Labs Closes $2.85 M in New Financing

XOR-Labs Toronto (XOR) a spin-oXOR-Labs Toronto (XOR) a spin-off from Toronto General Hospital at University Health Network today announced the closing of another financing through a private placement, led by lead investor Regenesis Limited Partnership, along with the participation of its existing investors, including Xenios AG and MaRS Innovation. The total raised in this round is CAN$2.85M. This is a solid vote of confidence and the second investment in XOR for Xenios which invested an additional CAN$2.6M in the company in ... Read more

ScarX announces approval for trial of first clinically-promising scar reduction cream

Toronto, August 18, 2016 – Toronto-based ScarX Therapeutics (ScarX) has received approval from Health Canada to begin a Phase I clinical trial of its SCX-001 nefopam cream, a first-of-its-kind topical treatment developed to significantly reduce surgical scarring. This announcement was covered in Yahoo Finance, The Canadian Business Journal, Global News Wire, and BioSpace. Applied immediately after surgical wound closure, SCX-001 reduces the amount of scar tissue that develops during the body’s natural healing process. The 24-subject Phase I clinical trial will be conducted at ... Read more

Triphase announces positive results of phase 1 trial of Marizomib and Bevacizumab in malignant glioma

TORONTO and SAN DIEGO (June 4, 2016) — Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, today announced positive results from its Phase 1 proof-of-concept study evaluating marizomib in combination with bevacizumab in patients with WHO grade IV malignant glioma. These results were presented in a poster session during the American Society for Clinical Oncology (ASCO) annual meeting in Chicago on June 4, 2016. “These results confirm our original hypothesis that this combination therapy is ... Read more

MaRS Innovation: Ahead of Innovation video launched

To coincide with our presence at the 2016 BIO International Convention (BIO) from June 6-9, 2016, MaRS Innovation launched a video explaining our role in Canada's innovation ecosystem: backing big thinkers with bold ideas and working with them to take those breakthroughs to market. This year, BIO takes place in San Francisco, California, the birthplace of biotech. MaRS Innovation will be present in the Ontario Pavilion (Booth #5944) in partnership with the Ontario Government and Life Sciences Ontario. Both the Honourable Navdeep Bains, Canada's ... Read more

Video: DashMD’s CEO and co-founder interviewed by Dx3 Canada

Amber Mac from Dx3 Canada interviewed Zack Fisch, CEO and co-founder of DashMD. In the video, Zack discusses DashMD's vision for a better healthcare system and what the company is doing in order to improve the discharge process for patients. About DashMD Dash MD seeks to improve the quality of healthcare by providing patients with the necessary tools, information, and resources that they need to successfully traverse their own personal and individualized road to recovery. Their Patient Engagement Platform will be downloadable to patients in ... Read more

Israel’s BioLineRx and Canada’s MaRS Innovation sign framework collaboration agreement

Agreement signed as part of Ontario's life sciences trade mission to Israel TEL AVIV and TORONTO (May 16, 2016) – BioLineRx Ltd. a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has signed a framework collaboration agreement with MaRS Innovation,  the commercialization agent for 15 of Toronto's top academic institutions. Under the terms of the agreement, BioLineRx intends to review innovative projects and assets of start-up companies originating from MaRS Innovation's members to identify in-licensing, co-development or other ... Read more

Ryerson University to host Dr. Daniel Kraft on Future of Health and Medicine

MaRS Innovation and the Ontario Centres of Excellence among the event's sponsors On Tuesday, May 31, 2016, Diane Francis, the first woman editor of a national daily newspaper in Canada and a distinguished professor at the Ted Rogers School of Management, will guide a conversation that begins with a keynote address by Dr. Daniel Kraft, one of the world’s foremost health experts and innovators whose ideas and work are shaping digital health. Dr. Daniel Kraft will be sharing his insights and experiences as ... Read more
Page 1 of 41234